<DOC>
	<DOCNO>NCT00002422</DOCNO>
	<brief_summary>The purpose study see safe effective give HE2000 , experimental anti-HIV drug , HIV-infected patient salvage therapy ( emergency treatment use patient respond standard therapy ) . HE2000 hormone suspect make difficult HIV live cell .</brief_summary>
	<brief_title>A Study Safety Anti-HIV Activity HE2000 HIV-Infected Patients Salvage Therapy</brief_title>
	<detailed_description>HE2000 synthetic steroid hormone , test laboratory , anti-viral activity wild-type drug-resistant variant HIV . HE2000 work natural biochemical mechanism cell make less able support viral infection . There 4 treatment group increase dos HE2000 ; group consist 2 part ( Part A B ) . Part A single administration HE2000 inject intramuscularly , Part B 5 consecutive daily intramuscular injection HE2000 . Patients receive dosage throughout Parts A B study . Patients ask return clinic periodically blood sample collection . Patients may remain hospital overnight pharmacokinetic evaluation . Drug safety , tolerance , efficacy , pharmacokinetics measure . Samples treatment Group 4 analyze specific cell function .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are least 18 year old . Are HIVpositive . Have current antiHIV drug combination least 30 day prior screen visit . Are currently fail least second antiHIV drug treatment . Are respond current antiHIV treatment , fail least 1 antiHIV combination , many option treatment ( Groups 3 4 ) . Are willing make change antiHIV treatment least Day 50 study . Have CD4 count least 100 cells/mm3 study entry . Have viral load ( level HIV body ) 5,000 250,000 copies/ml study entry . Agree use barrier method birth control ( e.g. , condom ) study . Exclusion Criteria Patients eligible study : Have hepatitis B C. Have treat cancer within 4 week prior study entry , need treat study . ( Patients Kaposi 's sarcoma eligible must receive treatment within 4 week study entry require treatment study . ) Have receive certain medication include affect immune system . Are pregnant breastfeeding . Have active , serious infection , include opportunistic ( AIDSdefining ) infection require treatment study 2 week prior study entry . Have condition receiving therapy would prevent complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2002</verification_date>
	<keyword>Injections , Intramuscular</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Salvage Therapy</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>